Philipp Freese
Corporate Officer/Principal bij MAINZ BIOMED N.V.
Vermogen: 372 831 $ op 31-03-2024
Profiel
Philipp Freese has held the following positions in his career: Co-Managing Director at PharmGenomics GmbH since 2013 and Chief Business Officer at Mainz Biomed NV since 2015.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
MAINZ BIOMED N.V.
2.16% | 26-03-2024 | 361 972 ( 2.16% ) | 372 831 $ | 31-03-2024 |
Actieve functies van Philipp Freese
| Bedrijven | Functie | Begin |
|---|---|---|
| MAINZ BIOMED N.V. | Corporate Officer/Principal | 01-07-2023 |
PharmGenomics GmbH
 PharmGenomics GmbH Medical SpecialtiesHealth Technology PharmGenomics GmbH develops diagnostic systems. Its offers PGx GenoChips and software. The firm also provides contract development and laboratory services. The company was founded by Moritz Eidens in 2008 and is headquartered in Maiz, Germany. | Chief Executive Officer | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| MAINZ BIOMED N.V. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
PharmGenomics GmbH
PharmGenomics GmbH Medical SpecialtiesHealth Technology PharmGenomics GmbH develops diagnostic systems. Its offers PGx GenoChips and software. The firm also provides contract development and laboratory services. The company was founded by Moritz Eidens in 2008 and is headquartered in Maiz, Germany. | Health Technology |
